Purpose: This study aimed to survey critical care clinicians and characterize their perception of antimicrobial dosing strategies in patients receiving extracorporeal membrane oxygenation (ECMO).
Methods: International, cross-sectional survey distributed to members of the Society of Critical Care Medicine in October 2022.
Results: Respondents were primarily physicians (45%), with 92% practicing in North America.
Background: Liposomal bupivacaine (LB) is increasingly being used for postoperative pain control, but there are conflicting efficacy data when compared with immediate-release bupivacaine (IRB).
Objective: To evaluate the comparative efficacies of LB and IRB for postoperative pain control in order to assess the formulary status of LB at our institution.
Methods: A single-center, retrospective, institutional review board-approved, noninferiority matched cohort study at a tertiary care academic medical center.